Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than good. A new study from University of California San Diego and Yale ...

Northwestern scientists have developed a new nanostructure that supercharges CRISPR’s ability to safely and efficiently enter cells, potentially unlocking its full power to treat genetic diseases. By ...

CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...

Genetic editing holds promise to treat incurable diseases, but the most popular method - CRISPR - sometimes does more harm ...

Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.

University of Hawaiʻi at Mānoa scientists have uncovered a direct link between a missing Y chromosome gene and male ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

PlantArcBio, an Israeli ag-biotech firm, has secured patents in the U.S. and South Korea for its DIPPER platform. This ...